Medication info
Olmexpos Tablets 5/40 mg (Amlodipine Besylate, Olmesartan Medoxomil)

Olmexpos Tablets 5/40 mg (Amlodipine Besylate, Olmesartan Medoxomil)

Prescription medicationTablet경구
Ingredient · strength
Amlodipine Besylate›6.944mg / 1 tabletOlmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
제이더블유중외제약(주)
Appearance
Pale yellow round film-coated tablet
Packaging
28 tablets (14 tablets/PTP x 2)
Approval status
Active

MFDS item code 201404592 · Approved 2014.10.06 · Insurance code 644913850

Summary

Main use
Hypertension blood pressure control improvement
Who takes it
Adults · Children
Adult dose
This medication is taken once daily, with one tablet taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled with monotherapy of amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: Administered to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy.
Child dose
The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established.

Ingredients

Manufacturer
제이더블유중외제약(주)

Efficacy & effects

Hypertension blood pressure control improvement

  • Essential hypertension
View approved original text

This medication is used when blood pressure is not well controlled with monotherapy of amlodipine or olmesartan medoxomil. It helps lower blood pressure to treat essential hypertension and is effective in reducing the risk of cardiovascular complications. It is used to maintain the health of hypertensive patients and improve blood pressure management.

How to take

Adult dose

This medication is taken once daily, with one tablet taken with water regardless of meals. It is recommended to take it at the same time each day (e.g., in the morning). The recommended dosages are as follows: - 5/20 mg: Administered to patients whose blood pressure is not adequately controlled with monotherapy of amlodipine 5 mg or olmesartan medoxomil 20 mg. - 10/20 mg: Administered to patients whose blood pressure is not adequately controlled with olmesartan medoxomil 20 mg monotherapy.

Child dose

The safety and efficacy of this medication in pediatric patients under 18 years of age have not been established.

Precautions

This drug can cause serious harm to the fetus and newborn when taken during the second and third trimesters of pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used if there is an allergy to any of the ingredients, if pregnant or nursing, or in patients with severe liver impairment, those undergoing renal dialysis, or those with severe aortic stenosis. When starting this medication in a state of dehydration or electrolyte deficiency, hypotension may occur, so treatment should be started with careful monitoring. Since vascular dilation can lead to a rapid drop in blood pressure, caution is required in patients with severe aortic stenosis. Patients with heart problems, particularly those with heart failure or obstructive coronary artery disease, should use this medication cautiously, with continuous monitoring of their condition during treatment. Patients with renal impairment may experience further worsening of renal function when taking this medication. Patients with impaired liver function should also be cautious when taking this drug and may require dose adjustments. During treatment, side effects such as dizziness, headache, hypotension, orthostatic hypotension, fatigue, swelling, nausea, constipation, rash, etc. may occur; if symptoms are severe, consult a healthcare professional. Particularly, potassium levels in the blood may increase, so those taking potassium supplements or potassium-sparing diuretics should have potassium concentration monitored regularly. This drug may interact with other antihypertensive medications or specific drugs; therefore, if taking other medications, it is crucial to inform the doctor or pharmacist. Women who are pregnant or planning to become pregnant should be switched to other antihypertensive agents whose safety has been established, and the use of this drug should be discontinued as soon as pregnancy is confirmed. Since this drug may pass into breast milk and cause side effects in infants, nursing mothers should either discontinue breastfeeding or stop taking this medication. This medication is not recommended for children under 18 years of age as its safety and efficacy in this population have not been established. Older patients may have reduced renal and liver function, thus treatment should start at a lower dose with careful dose adjustments. In cases of overdose, symptoms such as hypotension and tachycardia may occur, necessitating immediate treatment in a medical facility while continuously monitoring blood pressure and heart function. This medication should be stored in a tightly closed container to prevent air and moisture from entering and should be kept at a cool room temperature between 1 and 30 degrees Celsius. It is important to avoid direct sunlight and not to place it in excessively hot or cold places.

Side effects and when to seek care immediately

Serious side effects

Hives, chest tightness, difficulty breathing, angioedema, hives, severe swelling (edema), severe liver impairment-related jaundice, elevated liver enzymes, toxic epidermal necrolysis, cholelithiasis, acute renal failure, decreased urination (oliguria), severe edema accompanied by increased blood pressure, worsening of cerebrovascular accident, gum bleeding

Mild side effects

  • Dizziness
  • headache
  • drowsiness
  • paresthesia
  • palpitations
  • nausea
  • vomiting
  • dyspepsia
  • diarrhea
  • constipation
Show 20 more
  • dry mouth
  • upper abdominal pain
  • rash
  • decreased libido
  • vascular swelling
  • erectile dysfunction
  • peripheral edema
  • swelling
  • pitting edema
  • fatigue
  • weakness
  • decreased serum potassium
  • increased serum creatinine
  • increased serum uric acid
  • increased gamma-glutamyl transferase
  • decreased hemoglobin and hematocrit
  • orthostatic dizziness
  • laryngitis
  • arthritis
  • generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to prevent air or moisture from entering and kept at a cool room temperature between 1 and 30 degrees Celsius. It is crucial to avoid direct sunlight and not to expose it to extreme heat or cold.

Appearance and packaging

Appearance

Pale yellow round film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.